A financial statement detailing stock holdings as of April 2, 2014, including descriptions, trade dates, quantities, current prices, unit costs, market values, total costs, and unrealized gains/losses for various biotech companies.
doj/DataSet10/EFTA01447189.pdf
{"document_date":"2014-04-02","document_type":"tabular","document_subtype":"financial statement","key_organizations":["Sangamo Biosciences","Biogen","Foundation Medicine","Gilead Sciences Inc","Ariad Pharmaceuticals"],"reference_numbers":["DB-SDNY-0101745","SDNY_GM_00247929","EFTA01447189"]}